Article info

Protocol
Study protocol for a multicentre, 2×2 factorial, randomised, controlled trial evaluating the interest of intravenous iron and tranexamic acid to reduce blood transfusion in hip fracture patients (the HiFIT study)

Authors

  1. Correspondence to Professor Sigismond Lasocki; sigismond{at}lasocki.com
View Full Text

Citation

Lasocki S, Loupec T, Parot-Schinkel E on behalf of the HiFIT Study Group, et al
Study protocol for a multicentre, 2×2 factorial, randomised, controlled trial evaluating the interest of intravenous iron and tranexamic acid to reduce blood transfusion in hip fracture patients (the HiFIT study)

Publication history

  • Received June 21, 2020
  • Revised December 20, 2020
  • Accepted December 21, 2020
  • First published January 17, 2021.
Online issue publication 
January 17, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.